ETF Battles: Which Pharmaceutical ETF Should You Buy? Watch PPH vs. PJP vs. XPH!

In this episode of ETF Battles, Ron DeLegge @ETFguide referees an audience requested triple-header contest between a trio of pharmaceutical ETFs from Invesco (PJP), State Street Global Advisors (SSgA) and VanEck (PPH).

Program judges David Dierking with TheStreet.com and Tom Psarofagis with Bloomberg Intelligence judge the ETF match-up, sharing their investing research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle!

*********
ETF Battles is sponsored by:
Direxion Daily Leveraged & Inverse ETFs. Know the risks. Proceed Boldly. Visit http://www.Direxion.com

*********
Get in touch with our judges:
David Dierking (TheStreet.com)
https://etffocus.substack.com/archive

Tom Psarofagis (Bloomberg Intelligence)
https://www.bloomberg.com/authors/ATfFGwQL3tk/athanasios-psarofagis

*********
–YOUR RESOURCES FROM RON–
Get Ron’s weekly newsletter https://tinyurl.com/2p8bxy82
Free ETF Guides https://tinyurl.com/4uvfx4m7
Get help with your investing habits https://tinyurl.com/2xrpbzz8
Get feedback on your portfolio’s risk https://tinyurl.com/cz4ahj52

#PharmaStocks #BiotechETF #ETF

Facebook
Twitter
LinkedIn

Your Resources From ETFguide

Get Feedback on Your Portfolio's Risk

Check Your Investment Performance

Get Help With Your Investing Habits

60 Smart Ways to Retire Better

0

Your Cart is Empty